Lenacapavir could sharply cut new HIV infections.

But only if people can actually get it.

Watch this brief video from @maybarduk.bsky.social on how monopoly power is limiting access, and why World AIDS Day is the moment to demand change.

www.instagram.com/p/DRh2CUIjl-Z/

Big Pharma and its allies hired over 500 lobbyists this year to push 3 bills to erode a landmark reform that lets Medicare negotiate lower drug prices, according to our new report.

Their lobbyist hires outnumbered public interest advocates fighting the bad bills by 20-to-1.

Trade agreements must not stand in the way of health and access to medicines.

USMCA must be revised to remove extreme intellectual property provisions that keep medicine prices high, discourage competition, and ultimately impede access to medicine.

Thanks to health leaders Emily Bass, Mitchell Warren, Asia Russell, Amanda Banda, and Isata Dumbuya. And to our event co-hosts UNAIDS, Health GAP, People's Medicines Alliance, UAEM, Treatment Action Group, RESULTS, and Partners In Health.

We had a critical discussion about continuing the fight to bring medicines to all, with the first step being bringing that breakthrough — at that price — to the world.

Thanks to UNAIDS' Winnie Byanyima and Unitaid's Tenu Avafia for joining us today and for your leadership.

This week, the world learned that a new HIV prevention drug will be available for $40/year in 120 countries by 2027.

Yet millions of people in countries with growing HIV crises still are left out.

Today, health groups came together to support access for everyone, everywhere.